Literature DB >> 1769986

Diagnosis and indications for surgical treatment.

A C Smith1.   

Abstract

Dupuytren's disease is a common problem in most hand surgery practices. It is usually easily diagnosed by the presence of its primary palmar manifestations: the nodule, the cord, and the digital flexion contracture. The isolated nodule may occasionally require biopsy to rule out the possibility of malignancy, but this is unusual. The nodule is typically the first lesion to appear and is the site of active biologic activity. The cord is the pathologically thickened and shortened normal longitudinal fascial structure of the palm and digit. Its insertion distal to the MPJ or PIP accounts for the progressive flexion contracture of these joints. Secondary findings include knuckle pads, plantar fascial nodules, and penile fascial contracture, which may signal the presence of Dupuytren's diathesis, a particularly aggressive form of the disease. The need and advisability of surgical intervention should be determined in close consultation with the patient after becoming thoroughly familiar with functional deficits and specific functional goals. A flexion contracture of more than 30 degrees at the MPJ or any contracture at the PIP is generally thought to be an indication for palmar fasciectomy. Patients should be aware of potential complications, those in higher risk categories should be identified preoperatively. Details of the operative procedure and variations in technique are discussed in subsequent articles in this issue.

Entities:  

Mesh:

Year:  1991        PMID: 1769986

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  15 in total

Review 1.  Dupuytren's contracture unfolded.

Authors:  W A Townley; R Baker; N Sheppard; A O Grobbelaar
Journal:  BMJ       Date:  2006-02-18

2.  Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings.

Authors:  Sandip Hindocha; John K Stanley; James Stewart Watson; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2007-09-11

3.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

4.  Unusual pattern of the first dorsal metacarpal artery.

Authors:  Homero Bianchi; Diego Saravia; Nicolas Ernesto Ottone
Journal:  Surg Radiol Anat       Date:  2017-01-30       Impact factor: 1.246

5.  Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.

Authors:  Raghuveer C Muppavarapu; Michael J Waters; Matthew I Leibman; Mark R Belsky; David E Ruchelsman
Journal:  Hand (N Y)       Date:  2015-06

6.  Carpal tunnel syndrome in pregnancy.

Authors:  G G Nicholas; R B Noone; W P Graham
Journal:  Hand       Date:  1971-03

7.  Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.

Authors:  F Alberton; M Corain; A Garofano; L Pangallo; A Valore; V Zanella; R Adani
Journal:  Musculoskelet Surg       Date:  2013-11-20

8.  The incidence of postoperative flare reaction and tissue complications in Dupuytren's disease using tension-free immobilization.

Authors:  Michael Rivlin; Meredith Osterman; Sidney M Jacoby; Terri Skirven; Uzoma Ukomadu; A Lee Osterman
Journal:  Hand (N Y)       Date:  2014-12

9.  Assessment of potential cross-reactivity of human endogenous matrix metalloproteinases with collagenase Clostridium histolyticum antibodies in human sera obtained from patients with Dupuytren's contracture.

Authors:  Thomas J Edkins; Roland Koller-Eichhorn; Jack A Alhadeff; Ulrich Mayer; Heinrich Faust; Benjamin J Del Tito
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

10.  Modified percutaneous needle aponeurotomy for the treatment of dupuytren's contracture: early results and complications.

Authors:  Fernando A Herrera; Scott Mitchell; Mark Elzik; Jason Roostaeian; Prosper Benhaim
Journal:  Hand (N Y)       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.